Health
Waisman Biomanufacturing partners with Heat Biologics to manufacture COVID-19 vaccine – Mirage News
Waisman Biomanufacturing staff operate a centrifuge that allows for cell separation. The UW-Madison biopharmaceutical contract manufacturer is partnering…
Waisman Biomanufacturing staff operate a centrifuge that allows for cell separation. The UW-Madison biopharmaceutical contract manufacturer is partnering with Heat Biologics to produce a COVID-19 vaccine for phase 1 and phase 2 clinical trials. Todd Brown, Media Solutions, UW School of Medicine and Public Health
Waisman Biomanufacturing at the University of Wisconsin-Madison is partnering with Heat Biologics to produce a COVID-19 vaccine for phase 1 and phase 2 clinical trials. Phase 1 trials c…
-
General11 hours agoICAC investigating University of Wollongong as chancellor grilled at Inquiry
-
General20 hours agoTwo people arrested after man fatally shot at McLaren Flat
-
General18 hours agoWarner Bros Discovery board rejects rival $163bn bid from Paramount
-
Noosa News11 hours agoE-Scooter accident | Noosa Today